SEFULLNESS OF HOMOEOPATHIC MEDICINE ZINCUMMETALLICUM IN HYPOTHYROID PATIENTS
Phase 3
- Conditions
- Health Condition 1: E038- Other specified hypothyroidism
- Registration Number
- CTRI/2022/10/046527
- Lead Sponsor
- DrGouthamy Sasikumar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients from 18 to 65 years of age, both genders
2. Patient having increased TSH value from 5-50 uIu/ml.
Exclusion Criteria
Cases with marked TSH level variations above 50 uIu/ml, multi-nodular
goitres and malignant thyroid tumours.
Patients with other severe systemic illness like uncontrolled diabetes,
malignant hypertension, other malignancies etc.
Immuno-compromised patients (AIDS, Cancer, TB)
Pregnant women and lactating mothers
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To find out the effectiveness of homoeopathic potentized medicine <br/ ><br>Zincum metallicum in reducing the TSH values in hypothyroid patientsTimepoint: Enrollment-6 months <br/ ><br>Follow up- 1 year
- Secondary Outcome Measures
Name Time Method To determine how the quality of life of hypothyroid patients improved <br/ ><br>using Billewicz scale. <br/ ><br> To taper the dosage of allopathic drugs in patients who are under <br/ ><br>Hormone replacement therapyTimepoint: Enrollment-6 months <br/ ><br>Follow up- 1 year